Second-line chemotherapy with paclitaxel for elderly patients with advanced gastric cancer

被引：0
|
作者：
Ohba, Akihiro
Takashima, Atsuo
Nishiuchi, Takamasa
Honma, Yoshitaka
Iwasa, Satoru
Okita, Natsuko
Kato, Ken
Hamaguchi, Tetsuya
Nagashima, Kengo
Boku, Narikazu
机构：
[1] Natl Canc Ctr, Gastrointestinal Med Oncol, 1-1 Tsukiji 5 Chome, Tokyo, Japan
[2] Kagawa Univ, Fac Med, Dept Clin Oncol, Kagawa, Japan
[3] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer
    Tomomi Yakabe
    Hirokazu Noshiro
    Osamu Ikeda
    Atsushi Miyoshi
    Yoshihiko Kitajima
    Seiji Satoh
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1499 - 1504
  • [22] Second line chemotherapy with paclitaxel and Carboplatin in advanced gastric cancer
    Papakostas, P
    Rigatos, S
    Stathopoulos, GP
    Samelis, G
    Polyzos, A
    Fountzilas, G
    ANNALS OF ONCOLOGY, 1998, 9 : 50 - 50
  • [23] Effects of weekly paclitaxel as a second-line anticancer chemotherapy for patients with advanced and recurrent gastric carcinoma
    Sakurai, Y
    Yoshida, I
    Masui, T
    Tonomura, S
    Shoji, M
    Nakamura, Y
    Uyama, I
    Komori, Y
    Kamoshida, S
    Tsutsumi, Y
    Ochiai, M
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 163 - 167
  • [24] Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    Catalano, V.
    Graziano, F.
    Santini, D.
    D'Emidio, S.
    Baldelli, A. M.
    Rossi, D.
    Vincenzi, B.
    Giordani, P.
    Alessandroni, P.
    Testa, E.
    Tonini, G.
    Catalano, G.
    BRITISH JOURNAL OF CANCER, 2008, 99 (09) : 1402 - 1407
  • [25] Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy
    Park, J.
    Park, S. H.
    Shin, D. B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 384 - 384
  • [26] Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy
    Se Hoon Park
    Woon Ki Lee
    Min Chung
    Soo-Mee Bang
    Eun Kyung Cho
    Jae Hoon Lee
    Dong Bok Shin
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 289 - 294
  • [27] Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy
    Park, SH
    Lee, WK
    Chung, M
    Bang, SM
    Cho, EK
    Lee, JH
    Shin, DB
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (03) : 289 - 294
  • [28] Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    V Catalano
    F Graziano
    D Santini
    S D'Emidio
    A M Baldelli
    D Rossi
    B Vincenzi
    P Giordani
    P Alessandroni
    E Testa
    G Tonini
    G Catalano
    British Journal of Cancer, 2008, 99 : 1402 - 1407
  • [29] Optimal indications for second-line chemotherapy in advanced gastric cancer
    Hasegawa, Hiroko
    Fujitani, Kazumasa
    Nakazuru, Shoichi
    Hirao, Motohiro
    Mita, Eiji
    Tsujinaka, Toshimasa
    ANTI-CANCER DRUGS, 2012, 23 (04) : 465 - 470
  • [30] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
    Otsuka, Ryo
    Iwasa, Satoru
    Yanai, Takako
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hashimoto, Hironobu
    Sekiguchi, Masatoshi
    Makino, Yoshinori
    Boku, Narikazu
    Yamaguchi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (04) : 595 - 601
12345